Uniportal thoracoscopic pulmonary segmentectomy provides good perioperative results and early postoperative recovery.
Uniportal video-assisted thoracoscopic surgery (U-VATS)
complex segmentectomy
segmentectomy
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
21
04
2022
accepted:
17
06
2022
entrez:
8
9
2022
pubmed:
9
9
2022
medline:
9
9
2022
Statut:
ppublish
Résumé
Although video-assisted thoracoscopic surgery (VATS) segmentectomy has become widespread, the advantage of uniportal VATS (U-VATS) segmentectomy over multiportal VATS (M-VATS) remains controversial. The purpose of this study was to verify the safety and usefulness of U-VATS segmentectomy compared with conventional hybrid/multiportal segmentectomy. Here, we retrospectively reviewed the data from anatomical pulmonary segmentectomy cases in a single institution from March 2010 to March 2021. Patients were divided into the U-VATS and hybrid/multiportal VATS (H/M-VATS) groups. Perioperative results were compared between the groups after matching for patient background characteristics. In addition, cases of complex segmentectomy were selected from each group and compared in terms of perioperative results. A total of 180 patients underwent pulmonary segmentectomy during the study period at this institution, comprising 57 cases in the U-VATS group and 123 cases in the H/M-VATS group. After matching for age, sex, disease, tumor location, and type of segmentectomy, no significant differences between the groups were seen in blood loss, major intraoperative bleeding, rate of conversion to thoracotomy, postoperative complications, or re-hospitalization within 30 days after discharge. Operation time (141±46 U-VATS segmentectomy appears as safe and feasible as H/M-VATS segmentectomy. An experienced surgeon can make a smooth transition to U-VATS.
Sections du résumé
Background
UNASSIGNED
Although video-assisted thoracoscopic surgery (VATS) segmentectomy has become widespread, the advantage of uniportal VATS (U-VATS) segmentectomy over multiportal VATS (M-VATS) remains controversial. The purpose of this study was to verify the safety and usefulness of U-VATS segmentectomy compared with conventional hybrid/multiportal segmentectomy.
Methods
UNASSIGNED
Here, we retrospectively reviewed the data from anatomical pulmonary segmentectomy cases in a single institution from March 2010 to March 2021. Patients were divided into the U-VATS and hybrid/multiportal VATS (H/M-VATS) groups. Perioperative results were compared between the groups after matching for patient background characteristics. In addition, cases of complex segmentectomy were selected from each group and compared in terms of perioperative results.
Results
UNASSIGNED
A total of 180 patients underwent pulmonary segmentectomy during the study period at this institution, comprising 57 cases in the U-VATS group and 123 cases in the H/M-VATS group. After matching for age, sex, disease, tumor location, and type of segmentectomy, no significant differences between the groups were seen in blood loss, major intraoperative bleeding, rate of conversion to thoracotomy, postoperative complications, or re-hospitalization within 30 days after discharge. Operation time (141±46
Conclusions
UNASSIGNED
U-VATS segmentectomy appears as safe and feasible as H/M-VATS segmentectomy. An experienced surgeon can make a smooth transition to U-VATS.
Identifiants
pubmed: 36071752
doi: 10.21037/jtd-22-555
pii: jtd-14-08-2908
pmc: PMC9442541
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2908-2916Commentaires et corrections
Type : CommentIn
Informations de copyright
2022 Journal of Thoracic Disease. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-555/coif). HI serves as an unpaid editorial board member of Journal of Thoracic Disease from August 2020 to July 2022. The other authors have no conflicts of interest to declare.
Références
Jpn J Clin Oncol. 2010 Mar;40(3):271-4
pubmed: 19933688
Ann Thorac Cardiovasc Surg. 2021 Aug 20;27(4):237-243
pubmed: 33239482
J Cardiothorac Surg. 2020 May 24;15(1):112
pubmed: 32448351
J Thorac Dis. 2021 Jan;13(1):244-251
pubmed: 33569204
J Thorac Dis. 2021 May;13(5):3001-3009
pubmed: 34164191
Eur J Cardiothorac Surg. 2021 Apr 13;59(3):650-657
pubmed: 33230524
Eur J Cardiothorac Surg. 2015 May;47(5):912-5
pubmed: 25147352
J Thorac Cardiovasc Surg. 2006 Oct;132(4):769-75
pubmed: 17000286
Eur J Cardiothorac Surg. 2016 Sep;50(3):411-5
pubmed: 27174549
Ann Thorac Surg. 2013 Feb;95(2):426-32
pubmed: 23219257
J Thorac Oncol. 2011 Apr;6(4):751-6
pubmed: 21325976
J Thorac Dis. 2016 Mar;8(Suppl 3):S279-86
pubmed: 27014475
J Thorac Dis. 2021 Nov;13(11):6331-6342
pubmed: 34992813
J Thorac Dis. 2021 Jul;13(7):4063-4071
pubmed: 34422336
Eur J Cardiothorac Surg. 2005 Jul;28(1):43-6
pubmed: 15927479
J Thorac Dis. 2018 Apr;10(4):2186-2195
pubmed: 29850122
J Thorac Dis. 2016 Oct;8(10):2872-2878
pubmed: 27867563
Interact Cardiovasc Thorac Surg. 2022 Jan 6;34(1):57-65
pubmed: 34999814
Eur J Cardiothorac Surg. 2021 Dec 27;61(1):100-107
pubmed: 34355732
Ann Thorac Surg. 2019 Apr;107(4):1032-1039
pubmed: 30550801
J Thorac Dis. 2019 Dec;11(12):5152-5161
pubmed: 32030232
Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):550-5
pubmed: 25634778
J Thorac Cardiovasc Surg. 2012 Mar;143(3):745-7
pubmed: 21868042
J Thorac Dis. 2018 Apr;10(Suppl 10):S1205-S1214
pubmed: 29785295
Interact Cardiovasc Thorac Surg. 2021 Apr 19;32(4):546-551
pubmed: 33313840
Eur J Cardiothorac Surg. 2016 Jan;49 Suppl 1:i37-41
pubmed: 26417062
Eur J Cardiothorac Surg. 2012 Apr;41(4):820-2; discussion 823
pubmed: 22219425